E. Gavriilidis

发表

Activin/Follistatin-axis deregulation is independently associated with COVID-19 in-hospital mortality

P. Rafailidis, P. Sideras, D. Boumpas, 2020, medRxiv.

Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure

I. Mitroulis, P. Skendros, V. Papadopoulos, 2022, Clinical Immunology.

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101

John D Lambris, B. Nilsson, S. Iacobelli, 2022, Science advances.

The Activin/Follistatin-axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality

B. Kalra, P. Rafailidis, P. Sideras, 2020, The Journal of infectious diseases.

Appraisal of the Current Guidelines for Management of Malignant Left-Sided Colonic Obstruction Using the Appraisal of Guidelines Research and Evaluation II Instrument

N. de’Angelis, A. Askari, P. Gavriilidis, 2021, Digestive Surgery.

Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure

I. Mitroulis, P. Skendros, V. Papadopoulos, 2022, Clinical Immunology.

Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling

P. Skendros, E. Xingi, V. Papadopoulos, 2023, Clinical Immunology.

Appraisal of the current guidelines for the management of diverticular disease using the Appraisal of Guidelines Research and Evaluation II (AGREE II) instrument.

N. de’Angelis, S. di Saverio, A. Askari, 2021, Annals of the Royal College of Surgeons of England.

IL-1β/DNA complex elevation distinguishes autoinflammatory disorders from autoimmune and infectious diseases.

P. Skendros, L. Chatzis, E. Gavriilidis, 2024, Journal of internal medicine.

Neutrophil-fibroblast crosstalk drives immunofibrosis in Crohn,s disease through IFNÎ± pathway

A. Giatromanolaki, P. Skendros, E. Synolaki, 2023, medRxiv.